Biovica International AB (publ) logo

Biovica International AB (publ)

SSE:BIOVIC-B.ST

Overview | Financials
Company Name Biovica International AB (publ)
Symbol BIOVIC-B.ST
Currency SEK
Price 2.34
Market Cap 182,015,262
Dividend Yield 0%
52-week-range 2.205 - 10.36
Industry Biotechnology
Sector Healthcare
CEO Mr. Anders Rylander
Website https://www.biovica.com

An error occurred while fetching data.

About Biovica International AB (publ)

Biovica International AB (publ), a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum, a biomarker assay that measures the activity of the enzyme thymidine kinase-1 in blood

Related Stocks

Paxman AB (publ) logo

Paxman AB (publ)

PAX.ST

38.6 SEK

ADDvise Group AB (publ) logo

ADDvise Group AB (publ)

ADDV-A.ST

11.6 SEK

Infant Bacterial Therapeutics AB (publ) logo

Infant Bacterial Therapeutics AB (publ)

IBT-B.ST

93.4 SEK

SpectraCure AB (publ) logo

SpectraCure AB (publ)

SPEC.ST

2.605 SEK

Xspray Pharma AB (publ) logo

Xspray Pharma AB (publ)

XSPRAY.ST

44 SEK

Orexo AB (publ) logo

Orexo AB (publ)

ORX.ST

14.5 SEK

Physitrack PLC logo

Physitrack PLC

PTRK.ST

15.2 SEK

Senzime AB (publ) logo

Senzime AB (publ)

SEZI.ST

7.25 SEK

Financials

Numbers are in millions USD

Numbers are in millions USD